Apixan Tablet 5 mg contains Apixaban 5 mg, a direct oral anticoagulant (DOAC) designed to prevent and treat blood clots in patients at risk of thromboembolic events. Apixaban works by selectively inhibiting Factor Xa, a crucial enzyme in the coagulation cascade, thereby reducing thrombin generation and clot formation while maintaining normal blood flow.

Apixan 5 mg is commonly prescribed for patients with non-valvular atrial fibrillation, deep vein thrombosis (DVT), pulmonary embolism (PE), and for thromboprophylaxis following orthopedic surgeries such as hip or knee replacement. The higher dose ensures optimal anticoagulation for adults requiring intensive thromboembolic protection under medical supervision.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Apixaban 5 mg

Mechanism of Action

Apixaban is a selective Factor Xa inhibitor. Its anticoagulant effect is achieved through:

• Direct inhibition of Factor Xa, preventing the conversion of prothrombin to thrombin

• Reducing thrombin production, which limits fibrin clot formation

• Allowing effective clot prevention while preserving normal hemostatic function

This targeted mechanism provides predictable anticoagulation without the frequent monitoring needed for traditional vitamin K antagonists like warfarin.

Indications

Apixan Tablet 5 mg is indicated for:

• Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation

• Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE)

• Prevention of recurrent DVT and PE after initial therapy

• Thromboprophylaxis following hip or knee replacement surgery in adults at risk

• Patients with high risk of thromboembolic events requiring long-term anticoagulation therapy

Benefits

• Effective Clot Prevention: Reduces risk of stroke, DVT, and PE

• Convenient Oral Administration: Twice-daily dosing ensures ease of use for long-term therapy

• Predictable Anticoagulant Effect: Fixed-dose therapy without routine coagulation monitoring

• Lower Risk of Major Bleeding: Compared to traditional anticoagulants in selected patients

• Supports Long-Term Management: Safe for ongoing use under physician supervision

Dosage and Administration

• The standard adult dose is 5 mg twice daily, or as recommended by a healthcare professional

• Tablets should be swallowed whole with water, with or without food

• Adherence to the prescribed dosing schedule is essential to maintain effective anticoagulation

• Dose adjustments may be needed in patients with renal impairment, low body weight, or concomitant medications

• Do not discontinue therapy without consulting a healthcare provider, as this may increase the risk of clot formation

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Safety and Precautions

• Common side effects include minor bleeding, bruising, or gastrointestinal discomfort

• Serious risks include major bleeding events, such as gastrointestinal bleeding or intracranial hemorrhage

• Avoid use in patients with active bleeding, severe liver disease, or known hypersensitivity to Apixaban

• Use caution in patients with renal impairment or those taking other anticoagulants or antiplatelet drugs

• Patients should report unusual bleeding, prolonged bruising, or other abnormal symptoms immediately

• Inform your healthcare provider of all medications, supplements, and medical conditions before starting therapy.